
Anthropic’s stock-market debut is the hottest ticket in finance right now, reportedly about six times oversubscribed before it has even priced. That sounds like a clean triumph. Then you look at who is doing the buying, and it starts to look like something closer to a very large, very expensive hall of mirrors.
The numbers
Anthropic is marketing shares at 70 to 78 dollars, which implies a valuation of roughly 1.4 trillion dollars. It is selling about 825 million shares to raise up to 64.4 billion dollars, alongside a simultaneous private placement of around 26 billion, for a combined total near 90 billion. Pricing is expected on 18 November, with trading under the ticker ANT starting the next day. Bloomberg reported on 12 November that the order book was about six times oversubscribed, and that bankers were warning buyers they would get smaller allocations than hoped because existing backers come first. The Financial Times has reported that banks are weighing a valuation of 1.5 trillion or higher.
Now the uncomfortable part
The same week, TSMC’s board approved spending up to 1 billion dollars buying preferred stock in OpenAI and common stock in Anthropic. The chipmaker that Anthropic pays to manufacture its silicon is also buying Anthropic’s shares. The cloud providers it rents its compute from are already investors. The money goes round and round the same small circle of firms, each one’s spending booked as another’s revenue, each one’s investment propping up the next one’s valuation.
When a company’s suppliers, customers and partners are also its shareholders, demand for the stock stops being a clean signal of worth. Six times oversubscribed means a great deal less when a chunk of those orders come from firms with a direct commercial interest in Anthropic looking colossal. And when bankers tell you existing backers get first call on the shares, what they are describing is not an open market. It is a members’ club, and the membership has every reason to keep the number going up.
Is it worth 1.4 trillion dollars
Nobody outside the room can say with a straight face that they know. Anthropic is a genuine frontier lab with a real, fast-growing enterprise business in Claude. It is also, like every lab of its kind, burning enormous sums to stay at the frontier, and a 1.4 trillion dollar price tag puts it in the company of the largest listed businesses on earth, firms with decades of profit behind them. The gap between that valuation and any disclosed profit is the entire argument, and the circular financing is exactly what makes that argument so hard to judge from the outside.
Bull, bear, neutral
Bull: Anthropic is one of a tiny handful of true frontier labs, Claude has real enterprise traction, and being able to raise 90 billion in one go is itself a durability advantage rivals cannot match. Scarcity of pure-play AI equity does the rest.
Bear: 1.4 trillion dollars on a loss-making company, with demand inflated by the very ecosystem it depends on. If the AI spending cycle cools, the whole interlocking structure cools together, because everyone is holding everyone else.
Neutral: watch the final price against the 70 to 78 range, the first day of trading, and the lock-up expiry when early backers can finally sell. And watch whether these circular supplier-shareholder deals keep multiplying, because that is the real tell.
Not investment advice. Do your own research, and for sums that matter, speak to a professional.
What this means
The oversubscription is real. So is the conflict of interest sitting inside it. An IPO this large, priced this high, bought in part by the same companies that supply and surround the business, is not pure price discovery. It is the AI industry buying its own story and selling it on to everyone else. The question is not whether people want the shares. It is whether that hunger means what the headline wants you to assume it means.
Edgar Friendly, calling the AI bullsh*t. More tools, more swearing: toptoolstack.com.
Did you know? If it prices at the top of its range, Anthropic’s debut would be among the largest share sales in history, by a company that did not exist a decade ago and does not yet turn a profit.
Sources: InvestingLive; Investing.com / Reuters; TradingKey; Crypto Briefing.